PROGRAMM JAHRESTAGUNG 2012 30. Nov. – 2. Dez ... - ÖGDV

Poster Tumore der Haut
P 45
The Prevalence of Primary Cutaneous Lymphomas at a Dermatology Referral
Center in Lower Austria
Andrea Kern 1
Johanna Eder 1,2
Melitta Kitzwoegerer 3
Roland Sedivy 3
Franz Trautinger 1,2
1 Landesklinikum St. Pölten, Karl Landsteiner Institut für Dermatologische Forschung,
Propst-Führer-Straße 4, A-3100 St. Pölten
2 Landesklinikum St. Pölten, Abteilung für Haut- und Geschlechtskrankheiten,
Propst-Föhrer-Straße 4, A-3100 St. Pülten
3 Landesklinikum St. Pölten, Institut für klinische Pathologie,
Propst-Führer-Straße 4, A-3100 St. Pölten
Introduction: In this retrospective analysis we evaluated the prevalence and the clinical
spectrum of primary cutaneous lymphomas (PCL) diagnosed and treated at the
Department of Dermatology in St. Pölten, Lower Austria, between 2006 and 2012. The
Department is a dermatology referral center providing secondary and tertiary care for
a population of about 600,000.
Methods: Pathology reports electronically archieved between 2006 and 2012 were
screened for the terms lymphoma, mycosis fungoides and lymphomatoid papulosis.
The resulting patient list was manually checked for errors and duplicates, verified and
correlated with patient records and history.
Results: We identified 56 patients (17 females and 39 males) with ages at diagnosis
ranging from 13 to 85 yrs and a median of 58 yrs. 43 pts (77%) had cutaneous T-cell
lymphomas (CTCL) and 13 pts (23%) had cutaneous B-cell lymphomas (CBCL). 33
patients were classified as mycosis fungoides (MF; stages: IA n=17, IB n=5, IIA n=2, IIB
n=8, III n=1). Large cell transformation was observed in 3 pts. Among pts with CTCL
other diagnoses were Sezary syndrome (n=2), lymphomatoid papulosis (n=6), CD4+
small/medium seized pleomorphic T-cell lymphoma (n=1), and subcutaneous
panniculitis-like T-cell lymphoma (n=1). CBCL was classified as follicle center lymphoma
in 6 patients, marginal zone lymphoma in 4 patients, and diffuse large B-cell lymphoma,
leg type, in 3 patients.
Conclusion: Our data correspond well with the published annual incidence of PCL
(0.5-1 per 100,000) and with the published distribution of separate disease entities. In
conclusion, for sufficiently large populations it appears reasonable to provide
specialized care for pts with PCL at centers with expertise in dermato-oncology.
101